PTPRC and inflammatory bowel disease: Analysis of expression by morphology region showed a decreased/absent expression of LYZ in CD3 and CD45-positive cells from patients with dysplasia/CRC in contrast to the significant elevation of expression in tissue from patients with IBD alone (logFC = 1.6; P = 0.001).